What does CUSIP 68232V116 represent in this 13F holders report?

CUSIP 68232V116 is the security identifier for ONTXW - ONCONOVA THERAPEUTICS INC - *W EXP 07/11/202 used to aggregate holder disclosures.

How many institutions held ONTXW - ONCONOVA THERAPEUTICS INC - *W EXP 07/11/202 in Q3 2021?

No institutional holders were reported for ONTXW - ONCONOVA THERAPEUTICS INC - *W EXP 07/11/202 in Q3 2021; review adjacent reporting periods for trend context.

202 (ONTXW)

CUSIP: 68232V116

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class: Equity / *W EXP 07/11/202
Total 13F shares: 0
Share change: -40,890
Total reported value: $0
Number of holders: 0
Value change: -$7,000
Number of sells: 2

Quarterly Holders Quick Answers

What is CUSIP 68232V116?
CUSIP 68232V116 identifies ONTXW - ONCONOVA THERAPEUTICS INC - *W EXP 07/11/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q2 2021

Recent filing periods for CUSIP 68232V116:

Q3 2021 Q2 2021 Q1 2021 Q4 2020 Q3 2020 Q2 2020 Q1 2020 Q4 2019

ONCONOVA THERAPEUTICS INC - *W EXP 07/11/202 (ONTXW)

Q3 2021 13F Holders as of 30 Sep 2021

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of ONTXW - ONCONOVA THERAPEUTICS INC - *W EXP 07/11/202 as of Q3 2021.